Dr. Xing is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Innovation Dr
Biotech 3
Worcester, MA 01605Phone+1 508-334-1000
Education & Training
UMass Chan Medical SchoolResidency, Pathology-Anatomic and Clinical, 2011 - 2015
Tongji Medical UniversityClass of 1994
Certifications & Licensure
CA State Medical License 2017 - 2025
MA State Medical License 2014 - 2025
NY State Medical License 2017 - 2019- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 5 citationsPD-L1 Immunohistochemistry Highlights Bone Marrow Involvement by Classic Hodgkin Lymphoma in Staging Biopsies: Implications for Diagnosis and Tumor Microenvironment Al...Wei Xing, Nicholas Mai, Karen Dresser, Benjamin J. Chen
Applied Immunohistochemistry & Molecular Morphology. 2017-12-01 - 50 citationsPD-L1 expression in EBV-negative diffuse large B-cell lymphoma: clinicopathologic features and prognostic implicationsWei Xing, Karen Dresser, Rui Zhang, Andrew M. Evens, Hongbo Yu
Oncotarget. 2016-08-04 - 46 citationsCerdulatinib, a novel dual SYK/JAK kinase inhibitor, has broad anti-tumor activity in both ABC and GCB types of diffuse large B cell lymphoma.Jiao Ma, Wei Xing, Greg Coffey, Karen Dresser, Kellie Lu
Oncotarget. 2015-11-13
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
